Arnaud Tiberghien

1.6k citations

25 papers · 900 indexed · h-index 16

Oncology top 5%
Radiology, Nuclear Medicine and Imaging top 5%
Molecular Biology
Organic Chemistry top 5%
Pathology and Forensic Medicine

Co-authors: Philip W. Howard John A. Hartley Luke A. Masterson David G. Williams Lauren Adams Simon Corbett François D’Hooge David E. Thurston
Topics: Synthesis and pharmacology of benzodiazepine derivatives (16 papers)Cancer therapeutics and mechanisms (12 papers)Cancer Treatment and Pharmacology (9 papers)
Cited by: Oncology Radiology, Nuclear Medicine and Imaging Organic Chemistry
Journals: Blood Cancer Research Chemical Communications
Partner nations: United Kingdom United States Australia

In The Last Decade

Arnaud Tiberghien

25 papers receiving 844 citations

Peers

Countries citing papers authored by Arnaud Tiberghien

Since Specialization

Citations

This map shows the geographic impact of Arnaud Tiberghien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnaud Tiberghien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnaud Tiberghien more than expected).

Fields of papers citing papers by Arnaud Tiberghien

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnaud Tiberghien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnaud Tiberghien. The network helps show where Arnaud Tiberghien may publish in the future.

Co-authorship network of co-authors of Arnaud Tiberghien

This figure shows the co-authorship network connecting the top 25 collaborators of Arnaud Tiberghien. A scholar is included among the top collaborators of Arnaud Tiberghien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnaud Tiberghien. Arnaud Tiberghien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Peroxide-cleavable linkers for antibody–drug conjugates 2023 ·Chemical Communications ·Nicola Ashman,Jonathan D. Bargh,Stephen J. Walsh,Ryan Greenwood,Arnaud Tiberghien,Jason S. Carroll,David R. Spring	17
2	Comparison of Pyrrolobenzodiazepine Dimer Bis-imine versus Mono-imine: DNA Interstrand Cross-linking, Cytotoxicity, Antibody–Drug Conjugate Efficacy and Toxicity 2022 ·Molecular Cancer Therapeutics ·Arnaud Tiberghien,Balakumar Vijayakrishnan,(unknown),(unknown),(unknown),John P. Bingham,Lauren Adams,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Ravinder Tammali,Edward Rosfjord,(unknown),John A. Hartley,Philip W. Howard	3
3	A single dose of antibody-drug conjugate cures a stage 1 model of African trypanosomiasis 2019 ·PLoS neglected tropical diseases ·Paula MacGregor,(unknown),(unknown),Martin C. Taylor,(unknown),Alan M. Sandercock,(unknown),Katrien Van Bocxlaer,Amanda Fortes Francisco,François D’Hooge,Arnaud Tiberghien,Conor S. Barry,Philip W. Howard,Matthew K. Higgins,Tristan J. Vaughan,Ralph Minter,Mark Carrington	12
4	Improved Inhibition of Tumor Growth by Diabody-Drug Conjugates via Half-Life Extension 2019 ·Bioconjugate Chemistry ·Qing Li,Allison Barrett,Balakumar Vijayakrishnan,Arnaud Tiberghien,(unknown),Keith Rickert,Kevin Allen,R. James Christie,Marcello Marelli,Jay Harper,Philip W. Howard,Herren Wu,William F. Dall’Acqua,Ping Tsui,Changshou Gao,M. Jack Borrok	19
5	An Isomerization Approach to Tesirine and Pyrrolobenzodiazepines 2019 ·Organic Process Research & Development ·Andrew D. Campbell,Simone Tomasi,Arnaud Tiberghien,Jeremy S. Parker	7
6	SLC46A3 as a Potential Predictive Biomarker for Antibody–Drug Conjugates Bearing Noncleavable Linked Maytansinoid and Pyrrolobenzodiazepine Warheads 2018 ·Clinical Cancer Research ·Krista Kinneer,John Meekin,Arnaud Tiberghien,Yu‐Tzu Tai,Sandrina Phipps,Christine Mione Kiefer,Marlon C. Rebelatto,Nazzareno Dimasi,Alyssa Moriarty,Kyriakos P. Papadopoulos,Sriram Sridhar,Stephen J. Gregson,Michael J. Wick,Luke A. Masterson,Kenneth C. Anderson,Ronald Herbst,Philip W. Howard,David A. Tice	58
7	Pre-clinical pharmacology and mechanism of action of SG3199, the pyrrolobenzodiazepine (PBD) dimer warhead component of antibody-drug conjugate (ADC) payload tesirine 2018 ·Scientific Reports ·John A. Hartley,Michael Flynn,John P. Bingham,Simon Corbett,(unknown),Arnaud Tiberghien,Luke A. Masterson,Dyeison Antonow,Lauren Adams,(unknown),David G. Williams,Shenlan Mao,Jay Harper,Carin E.G. Havenith,Francesca Zammarchi,Simon Chivers,Patrick H. van Berkel,Philip W. Howard	85
8	Scale-up Synthesis of Tesirine 2018 ·Organic Process Research & Development ·Arnaud Tiberghien,(unknown),Conor S. Barry,(unknown),Christian Noti,(unknown),(unknown),Philip W. Howard,Jeremy S. Parker	13
9	Synthesis and in vitro evaluation of SG3227, a pyrrolobenzodiazepine dimer antibody-drug conjugate payload based on sibiromycin 2017 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Arnaud Tiberghien,Neki V. Patel,François D’Hooge,(unknown),Lauren Adams,Simon Corbett,David G. Williams,John A. Hartley,Philip W. Howard	15
10	An optimised synthesis of SG3376, a non-cleavable antibody-drug conjugate pyrrolobenzodiazepine drug-linker 2017 ·Tetrahedron Letters ·Arnaud Tiberghien,Stephen J. Gregson,Luke A. Masterson,(unknown),(unknown),Lauren Adams,Neki V. Patel,Philip W. Howard	6
11	ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer–Containing Antibody–Drug Conjugate (ADC) Targeting CD25-Expressing Hematological Malignancies 2016 ·Molecular Cancer Therapeutics ·Michael Flynn,Francesca Zammarchi,Peter Tyrer,Ayse U. Akarca,Narinder Janghra,(unknown),Carin E.G. Havenith,(unknown),Arnaud Tiberghien,Luke A. Masterson,Conor S. Barry,François D’Hooge,Teresa Marafioti,Paul W.H.I. Parren,David G. Williams,Philip W. Howard,Patrick H. van Berkel,John A. Hartley	85
12	Design and Synthesis of Tesirine, a Clinical Antibody–Drug Conjugate Pyrrolobenzodiazepine Dimer Payload 2016 ·ACS Medicinal Chemistry Letters ·Arnaud Tiberghien,(unknown),Luke A. Masterson,Neki V. Patel,Lauren Adams,Simon Corbett,David G. Williams,John A. Hartley,Philip W. Howard	100
13	Abstract 2856: Pyrrolobenzodiazepine (PBD) dimers - potent next generation warheads in antibody drug conjugates (ADCs) targeted at both solid and haematological tumors. 2013 ·Cancer Research ·John A. Hartley,Luke A. Masterson,Stephen J. Gregson,(unknown),(unknown),(unknown),(unknown),Arnaud Tiberghien,(unknown),François D’Hooge,Lauren Adams,David G. Williams,(unknown),Philip W. Howard	1
14	SG2285, a Novel C2-Aryl-Substituted Pyrrolobenzodiazepine Dimer Prodrug That Cross-links DNA and Exerts Highly Potent Antitumor Activity 2010 ·Cancer Research ·John A. Hartley,(unknown),(unknown),(unknown),Marie Suggitt,Zhizhi Chen,Stephen J. Gregson,Luke A. Masterson,Arnaud Tiberghien,Janet M. Hartley,Chris Pepper,Thet Thet Lin,Chris Fegan,David E. Thurston,Philip W. Howard	43
15	Structure−Activity Relationships of Monomeric C2-Aryl Pyrrolo[2,1-c][1,4]benzodiazepine (PBD) Antitumor Agents 2010 ·Journal of Medicinal Chemistry ·Dyeison Antonow,Maciej Kaliszczak,(unknown),(unknown),Arnaud Tiberghien,(unknown),Teresa Barata,Sibylle Heidelberger,C. James,Mire Zloh,Terence C. Jenkins,Anthony P. Reszka,Stephen Neidle,Sylvie M. Guichard,Duncan I. Jodrell,John A. Hartley,Philip W. Howard,David E. Thurston	32
16	Synthesis of a novel C2/C2′-aryl-substituted pyrrolo[2,1-c][1,4]benzodiazepine dimer prodrug with improved water solubility and reduced DNA reaction rate 2009 ·Bioorganic & Medicinal Chemistry Letters ·Philip W. Howard,Zhizhi Chen,Stephen J. Gregson,Luke A. Masterson,Arnaud Tiberghien,(unknown),Min Fang,(unknown),(unknown),John A. Hartley,David E. Thurston	24
17	An asymmetric C8/C8′-tripyrrole-linked sequence-selective pyrrolo[2,1-c][1,4]benzodiazepine (PBD) dimer DNA interstrand cross-linking agent spanning 11 DNA base pairs 2008 ·Bioorganic & Medicinal Chemistry Letters ·Arnaud Tiberghien,David A. Evans,Konstantinos Kiakos,(unknown),John A. Hartley,David E. Thurston,Philip W. Howard	15
18	Design, Synthesis, and Biophysical and Biological Evaluation of a Series of Pyrrolobenzodiazepine−Poly(N-methylpyrrole) Conjugates 2006 ·Journal of Medicinal Chemistry ·Geoffrey Wells,(unknown),Philip W. Howard,Zara A. Sands,Charles A. Laughton,Arnaud Tiberghien,(unknown),Luke A. Masterson,(unknown),John A. Hartley,Terence C. Jenkins,Steven D. Shnyder,Paul M. Loadman,Michael J. Waring,David E. Thurston	67
19	Application of the Stille coupling reaction to the synthesis of C2-substituted endo–exo unsaturated pyrrolo[2,1-c][1,4]benzodiazepines (PBDs) 2004 ·Bioorganic & Medicinal Chemistry Letters ·Arnaud Tiberghien,(unknown),Philip W. Howard,David E. Thurston	8
20	Synthesis of novel C2-aryl pyrrolobenzodiazepines (PBDs) as potential antitumour agents 2002 ·Chemical Communications ·(unknown),(unknown),Arnaud Tiberghien,(unknown),Charles S. Matthews,Philip W. Howard,David E. Thurston	34

About Arnaud Tiberghien

Arnaud Tiberghien is a scholar working on Organic Chemistry, Oncology and Molecular Biology, having authored 25 papers that have together received 900 indexed citations. Recurring topics across this work include Synthesis and pharmacology of benzodiazepine derivatives (16 papers), Cancer therapeutics and mechanisms (12 papers) and Cancer Treatment and Pharmacology (9 papers). The work is most often cited by research in Oncology (591 citations), Radiology, Nuclear Medicine and Imaging (368 citations) and Organic Chemistry (329 citations). Arnaud Tiberghien has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Philip W. Howard, John A. Hartley, Luke A. Masterson, David G. Williams, Lauren Adams, Simon Corbett, François D’Hooge, David E. Thurston, Patrick H. van Berkel and Carin E.G. Havenith. Their work appears in journals such as Blood, Cancer Research and Chemical Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact